Fri, September 8, 2023
Thu, September 7, 2023
Wed, September 6, 2023
Tue, September 5, 2023
Fri, September 1, 2023

Andreas Argyrides Maintained (ASND) at Buy with Increased Target to $192 on, Sep 6th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-192-on-sep-6th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andreas Argyrides of Wedbush, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $187 to $192 on, Sep 6th, 2023.

Andreas has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 1 agrees with Andreas's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Initiated at Hold and Held Target at $89 on, Wednesday, June 14th, 2023


This is the rating of the analyst that currently disagrees with Andreas


  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $152 on, Thursday, June 1st, 2023

Publication Contributing Sources